These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 10974930

  • 21. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial.
    Burkes RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Jones D, Farooq S, McGlaughlin J, Ginsberg RJ.
    Lung Cancer; 2005 Jan; 47(1):103-9. PubMed ID: 15603860
    [Abstract] [Full Text] [Related]

  • 22. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG.
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [Abstract] [Full Text] [Related]

  • 23. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
    Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara D.
    J Clin Oncol; 2007 Jan 20; 25(3):313-8. PubMed ID: 17235046
    [Abstract] [Full Text] [Related]

  • 24. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
    Unsal M, Akpolat I, Kandemir B.
    Saudi Med J; 2003 May 20; 24(5):493-8. PubMed ID: 12847624
    [Abstract] [Full Text] [Related]

  • 25. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 20; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L.
    Lung Cancer; 2004 Oct 20; 46(1):87-98. PubMed ID: 15364136
    [Abstract] [Full Text] [Related]

  • 31. The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis.
    Lee HW, Choi JH, Lim HY, Park JS, Kim HC, Kang S, Oh YT, Chun M, Sheen SS, Oh YJ, Park KJ, Hwang SC.
    Neoplasma; 2006 Oct 20; 53(1):30-6. PubMed ID: 16416010
    [Abstract] [Full Text] [Related]

  • 32. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766
    [Abstract] [Full Text] [Related]

  • 33. [Correlation between magnetic resonance imaging findings and proliferating cell nuclear antigen expression in peripheral lung cancer].
    Xiang ZM, Hu YS, Zhao SY, Tan LL, Li ZH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec 01; 28(12):2230-2. PubMed ID: 19114366
    [Abstract] [Full Text] [Related]

  • 34. Relationship between apoptosis and immunohistochemical staining for proliferating cell nuclear antigen and Ki-67 in non-small cell lung cancer.
    Ishiwata N, Jinn Y, Tsukada Y, Inase N, Ichioka M, Yoshizawa Y.
    Anticancer Res; 2000 Dec 01; 20(3A):1445-50. PubMed ID: 10928055
    [Abstract] [Full Text] [Related]

  • 35. [Clinical significance of insulin-like growth factor-1 receptor in platinum-based chemotherapy for non-small cell lung cancer].
    Ning XH, Wang YZ, Bai CM, Li J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug 01; 32(4):366-70. PubMed ID: 20868591
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer.
    Ye X, Ling B, Xu H, Li G, Zhao X, Xu J, Liu J, Liu L.
    Medicine (Baltimore); 2020 Apr 01; 99(16):e19755. PubMed ID: 32311975
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer.
    Kawasaki M, Nakanishi Y, Kuwano K, Takayama K, Kiyohara C, Hara N.
    Eur J Cancer; 1998 Aug 01; 34(9):1352-7. PubMed ID: 9849416
    [Abstract] [Full Text] [Related]

  • 40. [Timing changes of apoptosis and proliferating cells nuclear antigen after intra-arteiral infusion chemotherapy for nasopharyngeal carcinoma].
    Meng ZW, He EH, Meng ZL, Lü SJ, Guo MH.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Aug 01; 14(8):357-8. PubMed ID: 12563896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.